Moderna reports surprise profit as it books deferred COVID vaccine sales
By Patrick Wingrove and Leroy Leo (Reuters) – Moderna Inc on Thursday reported a small profit of 19 cents per share instead of an expected loss as it booked more revenue in the first quarter from last year’s deferred orders for its COVID-19 vaccine than had been anticipated.Analysts expected a loss of $1.77 per share,…
